American Journal of Obstetrics & Gynecology
Volume 193, Issue 1 , Pages 118-124 , July 2005

Comparison of glyburide and insulin for the management of gestational diabetes in a large managed care organization

  • Gavin F. Jacobson, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Kaiser Permanente Northern California, San Francisco, CA
    • ,
  • Gladys A. Ramos, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Kaiser Permanente Northern California, San Francisco, CA
    • ,
  • Jenny Y. Ching, RN

      Affiliations

    • Regional Perinatal Service Center, Kaiser Permanente Northern California, Santa Clara, CA
    • ,
  • Russell S. Kirby, PhD, MS

      Affiliations

    • Department of Maternal and Child Health, School of Public Health, University of Alabama-Birmingham, Birmingham, AL
    • ,
  • Assiamira Ferrara, MD, PhD

      Affiliations

    • Division of Research, Kaiser Permanente Northern California, Oakland, CA
    • ,
  • D. Robin Field, MD

      Affiliations

    • Departments of Obstetrics and Gynecology, Kaiser Permanente Northern California, San Francisco, CA

References 

  1. Coustan DR. Gestational diabetes. Washington: American College of Obstetricians and Gynecologists; 2001;ACOG Practice Bulletin, Number 30
  2. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O. A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med. 2000;343:1134–1138
  3. Gabbe SG, Graves CR. Management of diabetes mellitus complicating pregnancy. Obstet Gynecol. 2003;102:857–868
  4. Gabbe SG, Gregory RP, Power ML, Williams SB, Schulkin J. Management of diabetes mellitus by obstetrician-gynecologists. Obstet Gynecol. 2004;103:1229–1234
  5. National Diabetes Data Group . Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes. 1979;28:1039–1057
  6. Shapiro SS, Wilk MD. An analysis of variance test for normality (complete samples). Biometrika. 1965;52:591–611
  7. Hellmuth E, Damm P, Molsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabet Med. 2000;17:507–511
  8. Keyes L, Rodman DM, Curran-Everett D, Morris K, Moore LG. Effect of K+ATP channel inhibition on total and regional vascular resistance in guinea pig pregnancy. Am J Physiol. 1998;275:H680–H688
  9. Ebeigbe AB, Cabanie M. In vitro vascular effects of cicletanine in pregnancy-induced hypertension. Br J Pharmacol. 1991;103:1992–1996
  10. Gilson G, Murphy N. Comparison of oral glyburide with insulin for the management of gestational diabetes mellitus in Alaska Native women. Am J Obstet Gynecol. 2002;187:S152
  11. Velazquez MD, Bolnick J, Cloakey D, Gonzalez JL, Curet LB. The use of glyburide in the management of gestational diabetes. Obstet Gynecol. 2003;101(4 suppl):88S
  12. Conway DL, Gonzales O, Skiver D. Use of glyburide for the treatment of gestational diabetes: the San Antonio experience. J Matern Fetal Neonatal Med. 2004;15:51–55
  13. Fines VL, Moore TR, Castle SL. A comparison of glyburide and insulin treatment in gestational diabetes mellitus on infant birth weight and adiposity. Am J Obstet Gynecol. 2003;189:S161
  14. Chmait R, Dinise T, Moore T. Prospective observational study to establish predictors of glyburide success in women with gestational diabetes mellitus. J Perinat. 2004;10:617–622
  15. Kremer CJ, Duff P. Glyburide for the treatment of gestational diabetes. Am J Obstet Gynecol. 2004;190:1438–1439

 Poster presentation at the Annual Meeting of the Society for Maternal-Fetal Medicine, February 2, 2005, Reno, Nev.Reprints not available from the authors.

PII: S0002-9378(05)00376-5

doi: 10.1016/j.ajog.2005.03.018

American Journal of Obstetrics & Gynecology
Volume 193, Issue 1 , Pages 118-124 , July 2005

Article Tools